Driver Gene - Globe Thesis

Keyword [Driver Gene] Result: 41 - 60 \| Page: 3 of 3
41.	Therapeutic Regimens For Advanced NSCLC With Wild-type Driver Genes And The Joint Inhibitory Effect Of Two Targets On A549 Cells
42.	Clinical Study Of Xiaoyan Decoction Combined With Chemotherapy For Maintenance Treatment Of Advanced Negative Driver Gene Non-small Cell Lung Cancer
43.	Correlation Between The Risk Of Lymph Node Metastasis And Common Driver Gene Mutations In Lung Adenocarcinoma
44.	Analysis Of Driver Gene Mutations And Clinical Characteristics Of Philadelphia Chromosome-negative Myeloproliferative Neoplasms
45.	Influence Of Peripheral Blood SII And PNI On The Prognosis ?B-? NSCLC With Negative Driver Gene
46.	Research On Identification Methods Of Cancer-related Driver Genes
47.	Study On The Influencing Factors Of Tumor Mutation Burden In Non-small Cell Lung Cancer Patients And Their Correlation Analysis
48.	Study On The Feature Of Lymphoma-associated Driver Gene Aberration For Double-expression Diffuse Large B Cell Lymphoma
49.	Correlation Between Extranodal Involvement And Lymphoma-associated Driver Gene Abnormality In Patients With Diffuse Large B-cell Lymphoma
50.	Clinical And Prognostic Analysis Of Multiple Primary Lung Cancers
51.	Correlation Analysis Of The Distribution And Clinical Characteristics Of Driver And Non-Driver Genes In Patients With Myeloproliferative Neoplasms
52.	Real-world Research On The Detection Of Driver Genes And Targeted Therapy For Advanced Non-small Cell Lung Cancer Guided By Second-generation Sequencing Technology
53.	Expression Of Rare Gene Mutation In Lung Adenocarcinoma Population And Its Clinical Significance
54.	Clinical Investigation Of Anlotinib Combined With Chemotherapy As First-Line Treatment For Advanced Driver Gene Wild-Type Lung Adenocarcinoma
55.	Study On The Detection Of Driver Gene Mutation In Sputum Supernatant Of Patients With Non-small Cell Lung Cancer
56.	Effect Of TIM-3 And CONUT Score On Locally Advanced And Advanced Stage Driver Gene Negative NSCLC Patients Treated With Radiotherapy
57.	Clinical Observation Of Carrelizumab Combined With Chemotherapy As First-Line Treatment In Advanced Non-Squamous NSCLC Negative For Driver Gene Mutations
58.	Research On Integrating Multi-omics Data Mining Driver Genes Of Gastric Adenocarcinoma
59.	Effect Of Double Mutation Of Gastrointestinal Stromal Tumor Driver Gene (KIT) On Gene Expression Of Downstream Key Signaling
60.	Explore The Origin Of Poorly And Well-differentiated Cancerous Lesions In A Patient With Gastric Adenocarcinoma Based On WGS Data
<<First <Prev Next> Last>> Jump to